Diagnosis

148 trials 73 recruiting

Filter these 148 trials by phase, country and sponsor.

Open in Search →

[68Ga]Ga-FAPI total body PET/CT for improving diagnostic sensitivity and preoperative staging in gastroesophageal cancer and pancreatic canc… Ended

2023-503632-41-01 Pancreatic cancer and gastroesophageal cancer (esophagu 4 2024-01-30
Exploratory study evaluating the relevance of [68Ga]Ga-PentixaFor for initial staging and therapeutic evaluation of symptomatic multiple mye… Ended

2024-516752-18-00 Multiple myeloma 4 2021-09-21
Screening for occult malignancy using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in patients with … Ended

2024-514703-34-00 Thromboembolic event 5 2020-09-08
L-carnitine as an adjunct treatment for septic shock patients with acute kidney injury: a multicentre, randomized, 2-parallel group, superio… Ended

2024-512508-21-00 shock septic 5 2018-01-12
Pharmacodynamics of a Fixed dose combination of 0.34% tropicamide and 2.5% phenylephrine hydrochloride, eye drop, Solution Ended

2024-517456-35-00 to obtain pre-operative mydriasis or for diagnostic pur 9 2025-10-08
Pilot study to explore the diagnostic value of gadopiclenol in pathological and radiological insights with multiparametric MRI enhancement i… Ended

2025-521810-24-00 Breast cancer 6 2025-09-22
BATOLISA Ended

2024-513529-21-00 Lipedema 6 2025-01-24
Randomized clinical trial comparing the diagnostic quality and diagnostic accuracy of pulmonary CT angiography performed with spectral CT am… Ended

2024-515246-17-00 pulmonary embolism 6 2024-11-11
A Study to Assess the Effectiveness of Different Doses of GEH200486 Injection for Contrast-enhanced Head and Neck MRI in Healthy Volunteers Ended

2024-516751-41-00 None - imaging technique 2 2024-11-08
BIOLOGICAL STANDARDISATION OF ALLERGENIC EXTRACTS OF MITES TO DETERMINE BIOLOGICAL ACTIVITY (IN HEP UNITS) IN SENSITIVISED PATIENTS. Ended

2024-513834-40-01 Allergies 4 2024-10-01
Comparison of 18F-Fluciclovine PET versus 18F-Fluoroethyltyrosine PET in patients with newly diagnosed cerebral gliomas, recurrent cerebral … Ended

2023-507786-26-00 Patients with newly diagnosed cerebral gliomas, recurre 4 2024-08-14
In vivo PET of synaptic density in cognitive disorders: prospective evaluation of neuronal dysfunction and relation to symptomatology. Ended

2024-514577-22-00 Cognitive Disorders including Alzheimer's Disease, Fron 3 2024-07-12
FDG-PET/CT versus conventional CT for response monitoring in metastatic breast cancer: A pilot study for a randomized clinical trial (MONITO… Ended

2023-506550-20-00 Metastatic breast cancer 10 2024-07-05
[68Ga]Ga-PentixaFor-PET imaging for staging of marginal zone lymphoma Ended

2022-500918-25-00 Marginal Zone Lymphoma 5 2024-05-20
Unravelling intestinal fibrosis in ulcerative colitis: INTERACT study Ended

2023-507907-73-00 Ulcerative colitis 11 2024-04-03
68Ga-FAPI PET/CT: The Diagnostic Accuracy for Primary Staging and Re-staging after Chemotherapy in Patients with Gastric and Gastro-Esophage… Ended

2023-505916-40-01 Gastroesophageal junction cancer (GEJ-cancer) 4 2024-02-15
Focus Green: Fluorescence-guided resection Of Colorectal liver metastases Using SGM-101 and Indocyanine GREEN Ended

2023-504615-33-00 colorectal livermetastases 4 2023-12-12
Contribution of PET (positron emission tomography) scans for the preoperative assessment of symptomatic endometriosis lesions: TEP-ENDORUN Ended

2024-520423-88-00 Endometriosis 5 2023-12-12
68Ga-FAPI PET/CT: The Diagnostic Accuracy for Primary Staging and Re-staging of Patients with Ovarian Cancer Ended

2023-505938-98-00 Ovarian Cancer 4 2023-11-17
A study to learn how gadoquatrane moves into, through, and out of the body and how safe it is in children aged 0 to less than 18 years, who … Ended

2022-501883-17-00 Contrast enhancement in magnetic resonance imaging in c 5 2023-10-16
A study to compare how well gadoquatrane works and its safety with an already available contrast agent for MRI in people with known or suspe… Ended

2022-501884-41-00 Contrast enhancement in magnetic resonance imaging for 5 2023-09-29
A study to compare the effects and safety of gadoquatrane with an already used available contrast agent for MRI tests in people with any kno… Ended

2022-501885-24-00 Contrast enhancement in magnetic resonance imaging for 5 2023-09-20
A Phase 1, Randomized, Double-Blind, Placebo and Positive-Controlled Crossover Study to Evaluate the Effect of Clinical and Supraclinical Do… Ended

2023-504310-30-00 Healthy volunteers 3 2023-08-16
68Ga satoreotide trizoxetan PET/CT in patients with high grade neuroendocrine lung cancer Ended

2023-503362-24-01 large cell neuroendocrine lung cancer 4 2023-08-09